Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome

Cardiovascular Revascularization Medicine

Volumn 12, Issue 6, 2011, Pages 385-390

  Mahmoudi, Michael ^a   Delhaye, Cedric ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Acute coronary syndrome; Bare metal stents; Drug eluting stents; ST elevation myocardial infarction

Indexed keywords

ABCIXIMAB; PACLITAXEL; RAPAMYCIN; TIROFIBAN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; BARE METAL STENT; CORONARY ARTERY RECANALIZATION; DISEASE REGISTRY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG INFUSION; DRUG MEGADOSE; DRUG SAFETY; FOLLOW UP; HEART INFARCTION; HEART REINFARCTION; HOSPITALIZATION; HUMAN; LONG TERM CARE; META ANALYSIS; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OFF LABEL DRUG USE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SINGLE DRUG DOSE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; STENT THROMBOSIS; TREATMENT INDICATION; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, BALLOON, CORONARY; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HUMANS; METALS; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 82755189955     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2011.01.001     Document Type: Review

References (36)

1. Anderson J, Adamas C, Antman E, Bridges C, Califf R, Casey D, Chavey W, Fesmire F, Hochman J, Levin T, Lincoff A, Peters E, Theroux P, Wenger N, Wright R. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: executive summary. Circulation 2007, 116:e148-e304.
2. Bassand J, Hamm C, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, Fox K, Hasdai D, Ohman M, Wallentin L, Wijns W Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007, 28:1598-1660.
3. Stone G, Moses J, Ellis S, Schofer J, Dawkins K, Morice M, Colombo A, Schampert E, Grube E, Kirtane A, Cutlip D, Fahy M, Pocock S, Mehran R, Leon M Safety and efficacy of sirolimus and paclitaxel eluting coronary stents. N Engl J Med 2007, 356:998-1008.
4. Morice M, Serruys P, Sousa J, Fajadet J, Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R A randomised comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002, 346:1773-1780.
5. Dibra A, Kastrati A, Alfonso F, Seyfarth M, Perez-Vizcayno M, Mehilli J, Schomig A Effectiveness of drug eluting stents in patients with bare metal in-stent restenosis. J Am Coll Cardiol 2007, 49:616-623.
6. Jeremias A, Sylvia B, Bridges J, Kirtane A, Bigelow B, Pinto D, Ho K, Cohen D, Garcia L, Cutlip D, Carrozza J Stent thrombosis after successful sirolimus eluting stent implantation. Circulation 2004, 109:1930-1932.
7. Daemen J, Wenaweser P, Tsuchisa K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, van Domburg R, Hess O, Boersma E, Meier B, Windecker S, Serruys P Early and late coronary stent thrombosis of sirolimus eluting and paclitaxel eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007, 369:667-678.
8. Finn A, Joner M, Nakazawa G, Kolodgie F, Newell J, John M, Gold H, Virmani R Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007, 115:2435-2441.
9. Chen B, Ma F, Luo W, Ruan J, Xie W, Zhao X, Sun S, Guo X, Wang F, Tian T, Chu X Neointimal coverage of bare metal and sirolimus eluting stents evaluated with optical coherence tomography. Heart 2008, 94:566-570.
10. Suarez A, Perez-Vizcayno M, Moreno R, Escaned J, Banuelos C, Jimenez P, Bernardo E, Angiolillo D, Hernandez R, Macaya C Intravascular ultrasound findings during episodes of drug eluting stent thrombosis. J Am Coll Cardiol 2007, 50:2095-2097.
11. Feres F, Costa J, Abizaid A Very late thrombosis after drug eluting stents. Catheter Cardiovasc Interv 2006, 68:83-88.
12. Farb A, Burke A, Kolodgie F, Virmani R Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003, 108:1701-1706.
13. Valgimigli M, Percoco G, Malagutti P, Campo G, Ferrari F, Barbieri D, Ciccitelli G, McFadden E, Merlini F, Ansani L, Gurdigli G, Bettini A, Parrinello G, Boersma E, Ferrari R Tirofiban and sirolimus-eluting stent vs abciximab and bare metal stent for acute myocardial infarction: a randomized trial. JAMA 2005, 2005:2109-2117.
14. Valgimigli M, Campo G, Arcozzi C, Malagutti P, Carletti R, Ferrari F, Barbieri D, Parrinello G, Percoco G, Ferrari R Two-year follow-up after sirolimus-eluting versus bare metal stent implantation assisted by systematic glycoprotein IIb/IIIa inhibitor infusion in patients with myocardial infarction: results from the STRATEGY study. J Am Coll Cardiol 2007, 50:138-145.
15. Tebaldi M, Arcozzi C, Campo G, Percoco G, Ferrari R, Valgimigli M The 5 year clinical outcomes after a randomized comparison of sirolimus-eluting versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2009, 54:1900-1910.
16. Spaulding C, Henry P, Teiger E, Beat K, Bramucci E, Carrie D, Slama M, Merkely B, Erglis A, Margheri M, Varenna O, Cebrian A, Stoll H, Snead D, Bode C Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006, 355:1093-1104.
17. Menichelli M, Parma A, Pucci E, Fiorilli R, De Felice F, Nazzaro M, Giulivi A, Alborino D, Azzellino A, Violini R Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol 2007, 49:1924-1930.
18. Valgimigli M, Campo G, Percoco G, Bolognese L, Vassanelli C, Colangelo S, de Cesare N, Rodriguez A, Ferrario M, Moreno R, Piva T, Sheiban I, Pasquetto G, Prati F, Nazzaro M, Parrinello G, Ferrari R Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. JAMA 2008, 299:1788-1799.
19. Laarman GJ, Suttorp MJ, Dirksen MT, van Heerebeek L, Kiemeneij F, Slagboom T, van der Wieken LR, Tijssen JG, Rensing BJ, Patterson M Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006, 355:1105-1113.
20. Chechi T, Vittori G, Zoccai G, Vecchio S, Falchetti E, Spaziani G, Baldereschi G, Giglioli C, Valente S, Margheri M Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION). J Interv Cardiol 2007, 20:282-291.
21. Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Mockel M, Ochala A, Kellock A, Parise H, Mehran R Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 2009, 360:1946-1959.
22. Kelbaek H, Thuesen L, Helqvist S, Clemmensen P, Klovgaard L, Kaltoft A, Andersen B, Thuesen H, Engstrom T, Botker HE, Saunamaki K, Krusell LR, Jorgensen E, Hansen HH, Christiansen EH, Ravkilde J, Kober L, Kofoed KF, Terkelsen CJ, Lassen JF Drug-eluting versus bare metal stents in patients with ST-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial. Circulation 2008, 118:1155-1162.
23. Di Lorenzo E, Sauro R, Varricchio A, Carbone G, Cortese G, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca M, Stanco G, Rosato A, De Luca G Long-tem outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel or sirolimus eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial. Circulation 2009, 120:964-972.
24. Di Lorenzo E, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Marriello C, Siano F, Pagliuca M, Stanco G, Rosato A, De Luca G. Benefits of drug eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: Four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial. AHJ 2009, 158:e43-e50.
25. Mauri L, Silbaugh T, Garg P, Wolf R, Zelevinsky K, Lovett A, Varma M, Zhou Z, Normand S Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008, 359:1330-1342.
26. Steg P, Fox K, Eagle K, Furman M, Van der Werf F, Montalecot G, Goodman S, Avezum A, Huang W, Gore J Mortality following placement of drug-eluting and bare metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J 2009, 30:321-329.
27. Hannan E, Racz M, Walford G, Holmes D, Jones R, Sharma S, Katz S, King S Drug-eluting versus bare metal stents in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 2008, 1:129-135.
28. Jensen L, Maeng M, Thayssen P, Kaltoft A, Tilsted H, Bottcher H, Lassen J, Hansen K, Krusell L, Rasmussen K, Pedersen K, Pedersen L, Paaske-Johnsen S, Sorensen H, Thuesen L Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction. Cir Cardiovasc Interv 2008, 1:176-184.
29. Brodie B, Stuckey T, Downey W, Humphrey A, Nussbaum M, Laurent S, Bradshaw B, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Simonton C Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction. Catheter Cardiovasc Interv 2008, 72:893-900.
30. Vlaar P, Rihal C, Singh S, Lennon R, Ting H, Bresnahan J, Holmes D Safety and efficacy of drug eluting stent for ST-segment elevation myocardial infarction in an unselected consecutive cohort. Catheter Cardiovasc Interv 2008, 71:764-769.
31. Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvanne M, Suttorp MJ, Violini R, Schomig A Meta-analysis of randomized trials on drug-eluting stents vs. bare metal stents in patients with acute myocardial infarction. Eur Heart J 2007, 28:2706-2713.
32. Stettler C, Allemann S, Wandel S, Kastrati A, Morice M, Schomig A, Pfisterer M, Stone GW, Juni P Outcomes associated with drug-eluting and bare metal stents: a collaborative network meta-analysis. Lancet 2007, 370:937-948.
33. Piscione F, Piccolo R, Cassese S, Galasso G, De Rosa R, D'Andrea C, Chiariello M Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis of randomised trials and an adjusted indirect comparison. EuroIntervention 2010, 5:853-860.
34. Kukreja N, Onuma Y, Garcia-Garcia H, Daemen J, van Domburg R, Serruys P The risk of stent thrombosis in patients with acute coronary syndromes treated with bare metal and drug-eluting stents. J Am Coll Cardiol Cardiovas Int 2009, 2:534-541.
35. Li Y, Torguson R, Syed AI, Ben-Dor I, Collins SD, Maluenda G, Scheinowitz M, Kaneshige K, Xue Z, Lemesle G, Satler LF, Suddath WO, Kent KM, Lindsay J, Pichard AD, Waksman R Effect of drug-eluting stents on frequency of repeat revascularization in patients with unstable angina pectoris or non-ST-elevation myocardial infarction. Am J Cardiol 2009, 104:1654-1659.
36. Lotan C, Meredith I, Mauri L, Liu M, Rothman MT E-Five Investigators. Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: 12- month data from the E-Five registry. JACC Cardiovasc Interv 2009, 2:1227-1235.